Success after a century of failures: Inside Moderna and Merck's cancer vaccine breakthrough

Success after a century of failures: Inside Moderna and Merck's cancer vaccine breakthrough  Reuters

A group of Hong Kong-listed biotechnology companies have seen their stock prices surge in the wake of Moderna’s breakthrough cancer vaccine trial, as the Chinese companies push forward with similar vaccine programmes. The companies – from Jiangsu Hengrui Pharmaceuticals to Li Ka-shing-backed CK Life Sciences – already